Vilket är priset för Lipidor AB (publ) (LIPI)

Priset för Lipidor AB (publ) (LIPI) är $0.02243487

Vilket är marknadsvärdet för Lipidor AB (publ) (LIPI)

Marknadsvärdet för Lipidor AB (publ) (LIPI) är $650.09K

Lipidor AB (publ) (LIPI) Intäkter

Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.

År	Intäkter	Ändra
2026 (TTM)	$265.61K	20,825.07%
2024	$1.27K	-83.58%
2023	$7.73K	79.16%
2022	$4.32K	-99.75%
2021	$1.70M	2,164.63%
2020	$75.02K	872.70%
2019	$7.71K	-71.64%
2018	$27.20K	-32.61%
2017	$40.36K	30.11%
2016	$31.02K	0.00%

År

Intäkter

Ändra

2026 (TTM)

$265.61K

20,825.07%

2024

$1.27K

-83.58%

2023

$7.73K

79.16%

2022

$4.32K

-99.75%

2021

$1.70M

2,164.63%

2020

$75.02K

872.70%

2019

$7.71K

-71.64%

2018

$27.20K

-32.61%

2017

$40.36K

30.11%

2016

$31.02K

0.00%

Företag	Intäkter	Intäktsdifferens	Land
Eli Lilly and Company LLY.US	$79.67B	29,992,925.40%	US
Johnson & Johnson JNJ.US	$97.93B	36,868,756.95%	US
AbbVie Inc. ABBV.US	$64.39B	24,240,300.94%	US
Roche Holding AG RO.SW	$77.52B	29,184,513.78%	CH
Merck & Co., Inc. MRK.US	$66.40B	24,998,542.91%	US

Företag

Intäkter

Intäktsdifferens

Land